What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News PepGen brings in gene therapy veteran to accelerate breakthrough neuromuscular treatments PepGen names gene therapy veteran Kasra Kasraian as CTO to scale up oligonucleotide therapies for neuromuscular diseases. Find out what this means for investors. byPallavi MadhirajuMay 20, 2025